Free Widgets | Feedback 
Live Share Markets - Appuonline.com


Updated:26 Jul 2017 03:31:00 PM(IST)

Investor Tool

My Stockwatch 

RELIANCE 1622.75 [ +1.29% ]TCS 2556.00 [ -0.60% ]

Sensex32382.46
154.19 0.48%

Nifty10020.65
56.10 0.56%

Midcap15339.76
27.16 0.18%

Smallcap16098.64
44.39 0.28%


Bse Corporate Announcements Back
Pharma Announces Positive Results of Two Pivotal Phase-3 Clinical Trials of Tildrakizumab
Sun Pharma announced that two pivotal Phase-3 clinical trials evaluating the efficacy and safety of the investigational IL-23p19 inhibitor antibody tildrakizumab (MK-3222) in patients with moderate-to-severe plaque psoriasis met their primary endpoints for both evaluated doses.

Market on Mobile
























Site Map  •  Mobile  •  Companies  •  Learning Centre  •  Insurance •  About  •  Contact us  •  Disclaimer
© appuonline.com